0001209191-24-002427.txt : 20240130 0001209191-24-002427.hdr.sgml : 20240130 20240130170404 ACCESSION NUMBER: 0001209191-24-002427 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240127 FILED AS OF DATE: 20240130 DATE AS OF CHANGE: 20240130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nguyen Diem CENTRAL INDEX KEY: 0001814338 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38436 FILM NUMBER: 24579065 MAIL ADDRESS: STREET 1: C/O VERRICA PHARMACEUTICALS INC. STREET 2: 10 NORTH HIGH STREET, SUITE 200 CITY: WEST CHESTER STATE: PA ZIP: 19380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SIGA TECHNOLOGIES INC CENTRAL INDEX KEY: 0001010086 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133864870 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 31 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 212-672-9100 MAIL ADDRESS: STREET 1: 31 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: SIGA PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961108 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-27 0 0001010086 SIGA TECHNOLOGIES INC SIGA 0001814338 Nguyen Diem C/O SIGA TECHNOLOGIES, INC. 31 EAST 62ND STREET NEW YORK NY 10065 1 1 0 0 Chief Executive Officer 0 Stock Option (Right to buy) 5.06 2024-01-27 4 A 0 109606 0.00 A 2034-01-27 Common Stock, par value $.0001 per share 109606 109606 D Stock Option (Right to buy) 5.06 2024-01-27 4 A 0 219212 0.00 A 2034-01-27 Common Stock, par value $.0001 per share 219212 219212 D Restricted Stock Units 2024-01-27 4 A 0 167707 0.00 A Common Stock, par value $.0001 per share 167707 167707 D Performance Stock Units 2024-01-27 4 A 0 177865 0.00 A Common Stock, par value $.0001 per share 177865 177865 D The options vest over two years, one-half on each of the first two anniversaries of the date of grant. The options vest over three years, one-third on each of the first three anniversaries of the date of grant. Restricted stock units ("RSUs") represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant. Performance stock units ("PSUs") represent contingent rights to receive Common Stock on a one-for-one basis. These PSUs vest as follows: (a) one-third of these PSUs vest if, during any period of 90 consecutive trading days during the three-year period beginning on the grant date (the "Performance Period"), the Issuer's Common Stock closing stock price (plus the per share value of any dividends issued during the measurement date) (the "Stock Price") is at or above $7.00, (b) one-third of these PSUs vest, if during any period of 90 consecutive trading days during the Performance Period, the Stock Price is at or above $8.00, and (c) one-third of these PSUs vest, if during any 90 consecutive trading days during the Performance Period, the Stock Price is at or above $9.00. /s/ Diem Nguyen 2024-01-30